Peripheral Intravascular Ultrasound (IVUS) Market Size, Share & Trends Analysis | Global | 2025-2032
Description
Global Peripheral Intravascular Ultrasound Market Report
By iData Research - 68 pages - 6 charts, 35 figures
Executive Summary
The global peripheral intravascular ultrasound market was valued at over $240 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 6.9% to reach $383 million by 2032.
The full report suite on the global market for peripheral intravascular ultrasound, or IVUS, covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and average selling price data, while also extending projections through 2032 to provide a forward-looking view of market development. This description follows the same structure and sequencing used in the attached example document, adapted to the peripheral IVUS market and its specific clinical and commercial dynamics .
This report provides detailed analysis of the global peripheral IVUS market, including unit sales, procedure numbers, average selling prices, market size, market shares, growth trends and forecasts through 2032, with historical data to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and competitive analysis of the leading participants in the category. Although this is a more specialized imaging segment within peripheral vascular intervention, it is becoming increasingly important because physicians are relying more heavily on real-time vessel visualization during complex procedures.
A major trend shaping the market is the ongoing development of high-definition imaging technologies and smaller catheter systems. These improvements are helping physicians visualize vessel structures more clearly and navigate more effectively during intervention. As a result, IVUS is becoming more valuable in lesion assessment, stent sizing, post-placement optimization and treatment of complex anatomy. This is especially relevant in procedures where angiography alone may not provide enough detail to support confident decision-making.
Growth is also being driven by expanding use in venous intervention and by the steady rise in peripheral procedure volume associated with aging populations and higher peripheral arterial disease prevalence.
Market Overview
The global peripheral intravascular ultrasound market includes catheter-based imaging devices used to visualize blood vessels from inside the lumen during peripheral vascular procedures. Unlike angiography, which shows vessel outlines using contrast and X-ray imaging, IVUS provides real-time cross-sectional information about vessel size, plaque burden, lumen shape and wall structure. This makes it an important tool in procedures where accurate anatomical understanding can improve treatment planning and final procedural results.
Peripheral IVUS has become more relevant as vascular interventions have grown more complex. Many peripheral procedures now involve long lesions, calcified anatomy, venous obstruction, difficult access routes or borderline sizing decisions for stent grafts and other implants. In these situations, physicians often need more precise information than angiography alone can provide. IVUS addresses that need by helping define vessel diameter, lesion length, plaque composition and true lumen position during the procedure itself.
Overall, the peripheral IVUS market is positioned between imaging, intervention and procedural planning. It is not a therapy by itself, but it plays a key enabling role in helping physicians make better decisions during treatment. That role is becoming more important as peripheral interventions continue moving toward more complex and more image-dependent care.
Market Drivers
Venous Treatments
One of the strongest drivers in the global peripheral IVUS market is the growth of venous treatment. Philips, the market leader in IVUS, actively positioned its products alongside venous intervention, and this strategy helped make IVUS closely associated with deep venous procedures. After the results of the VIDIO trial, use of IVUS became more established in venous cases involving the inferior vena cava, common iliac vein, iliofemoral obstruction and common femoral vein obstruction.
This is highly important because penetration rates of IVUS in deep venous treatments are already over 50%. That level of established use means venous procedures are not just a future opportunity. They are already a major source of demand. As more venous disease is diagnosed and treated, this part of the market is expected to contribute meaningful growth. Because IVUS provides sizing and lesion detail that venography alone may miss, it has become an important part of workflow in many of these cases.
Demographic Factors Drive Peripheral Procedures
Another major growth driver is the aging global population. Peripheral arterial disease becomes more common with age, especially in patients aged 65 and older. As the number of older adults rises worldwide, the total number of peripheral vascular procedures is expected to increase. Even if IVUS penetration rates within those procedures do not change dramatically, a larger procedural base still supports higher catheter unit sales.
This driver is structural and long term. It is not tied to one company or one indication. Instead, it reflects the fact that more patients will require vascular intervention as the burden of PAD grows. Because IVUS is increasingly used to guide peripheral interventions, growth in the total number of cases supports continued expansion of the imaging category.
Clinical Advantages of IVUS in EVAR and TEVAR Procedures
Peripheral IVUS is also supported by its advantages in EVAR and TEVAR procedures. In these cases, IVUS can help assess anatomy when CT-based measurements are borderline or when anatomy may have changed between the original scan and the actual intervention. It can also help confirm key dimensions before device deployment, which improves physician confidence in stent graft selection and placement.
IVUS also helps reduce the amount of radiographic contrast needed during EVAR and TEVAR. This is useful because contrast media can cause patient discomfort and can be undesirable in patients with renal risk. In dissection cases, IVUS provides especially valuable guidance because it can help confirm that equipment remains within the true vessel lumen. The ability of IVUS to identify dissections at a much higher rate than angiography makes it a practical and clinically meaningful support tool in complex aortic work.
These benefits are important because they show that IVUS is not only a lesion imaging tool. It also functions as a procedural confirmation technology in some of the more technically demanding vascular cases. As EVAR and TEVAR continue evolving, this should help support growing adoption.
Market Limiters
Capital Equipment Cost Limits Adoption
The biggest limiter in the global peripheral IVUS market is the cost of capital equipment. An IVUS system requires both the disposable catheter and the IVUS console. While catheter use creates recurring revenue, the console represents a major upfront investment. For cost-sensitive hospitals and facilities, this can delay adoption even when physicians see clinical value in the technology.
This matters because installed base drives long-term catheter demand. If facilities delay purchasing the console, catheter unit growth is naturally limited as well. Smaller centers or lower-volume accounts may find it difficult to justify the initial investment, especially when competing imaging or procedural priorities exist.
Fuzzy Images and Learning Curve
Another important limiter is the challenge of image interpretation. IVUS images can be difficult for untrained users to read. They are often grainy and do not always provide the kind of easily intuitive detail seen in some other imaging modalities. Physicians need training and practical experience before they are comfortable using the technology confidently in routine practice.
The training burden is not extreme, but it is real. Any technology that requires added interpretation skill creates a barrier to wider use, especially in accounts where physician time is limited or where procedural teams are already comfortable with angiography. This can slow uptake and favor more familiar imaging methods.
Developing Technologies
Peripheral IVUS also faces competition from developing technologies such as OCT and CT-based vascular imaging. These are not yet the standard in the periphery, but their broader use in coronary procedures and ongoing reimbursement efforts around newer technologies suggest they could become more influential over time.
One reason this matters is that some alternative imaging approaches can generate cleaner visuals or more three-dimensional anatomical models. These capabilities can be useful in identifying dissections, thrombi, tissue prolapse and incomplete stent apposition. As these technologies continue to mature, they are expected to cannibalize part of the IVUS market.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Qualitative Coverage
Market drivers and limiters, growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Time Frame
Base year 2025, historical data to 2022 and forecasts through 2032.
Regional Coverage
North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.
Data Types Included
Unit sales, average selling prices, procedure numbers, market size and growth trends.
This report is designed to support strategic planning and competitive benchmarking by combining detailed market sizing with practical insight into where IVUS creates value within peripheral intervention.
Markets Covered and Segmentation
The report covers the Global Peripheral Intravascular Ultrasound Market.
This market is analyzed as a dedicated imaging category within peripheral vascular intervention. While the report does not subdivide the category into multiple device families in the same way as some larger therapeutic markets, it evaluates the full market by units, ASPs, market value, growth rates and regional performance.
The analysis supports understanding of peripheral IVUS use across arterial, venous and EVAR or TEVAR-related procedures, with forecasts through 2032 and historical data to 2022.
Competitive Analysis
Philips held the leading position in the peripheral IVUS catheter market in 2025. The company offers a broad peripheral IVUS catheter portfolio that includes Visions PV .018, Visions PV .035, Visions PV .014P and Visions PV .014P RX. Its Eagle Eye Platinum and Eagle Eye Platinum ST catheters are also used in both coronary and peripheral procedures and are compatible with the Core and Core Mobile IVUS consoles. Philips has a major competitive advantage because its phased-array IVUS catheters are generally viewed as simpler and more workflow-friendly than rotational IVUS catheters. The company is also the only major supplier with a full range of 0.014 inch, 0.018 inch and 0.035 inch peripheral IVUS catheter options, which strengthens its position across both arterial and venous indications. Its especially strong presence in venous work remains one of the clearest supports for its leadership.
Boston Scientific ranked second in the peripheral IVUS catheter market in 2025. Its position is supported by the OptiCross18 peripheral IVUS catheter, which works with the iLab and POLARIS systems. Boston Scientific performs well in peripheral arterial disease indications because of its broad peripheral intervention portfolio and the ability to pair IVUS with complementary treatment devices. However, the company faces more difficulty in venous indications because its catheter size offering is not as broad as Philips’ lineup. This limits its competitive flexibility in some procedures and helps explain why Philips remains stronger in the venous segment.
Overall, competition in the peripheral IVUS market is shaped by catheter breadth, imaging workflow, installed console base and the ability to support both arterial and venous procedures through a coherent product portfolio.
Technology and Practice Trends
One of the most important trends in the peripheral IVUS market is the ongoing development of high-definition imaging technology. Better image quality improves vessel visualization and helps physicians make more confident decisions during intervention.
Another major trend is catheter miniaturization. Smaller catheter systems improve navigational capabilities and allow IVUS to be used more easily across different vessel types and procedural settings.
Venous adoption is also a key practice trend. IVUS is becoming strongly associated with deep venous intervention, and this is helping shift the market toward broader use in non-arterial cases.
Finally, IVUS is increasingly being used as a procedural optimization tool rather than only a diagnostic adjunct. Its role in sizing, confirming anatomy, reducing contrast use and guiding complex cases is expanding as operators seek more precision during intervention.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Deliverables
68 pages of detailed market analysis, segmentation and forecast data.
6 charts and 35 figures covering market performance, regional trends and competitive positioning.
Methodology Appendix and Acronym Glossary.
Licensing options include single-user, site and enterprise.
Why This Report
Where are the strongest growth opportunities in the global peripheral IVUS market through 2032?
How much of future expansion is being driven by venous procedures, PAD growth and EVAR or TEVAR support use?
What role do catheter miniaturization and higher-definition imaging play in future adoption?
How do capital costs, image interpretation challenges and alternative technologies limit broader market penetration?
Which companies lead the market, and how do their catheter portfolios shape their competitive positions?
How can suppliers and investors evaluate where peripheral IVUS fits within the broader future of image-guided vascular intervention?
The Global Peripheral Intravascular Ultrasound Market Report from iData Research answers these questions with detailed market sizing, pricing analysis, competitive intelligence and forecasting. Use it to benchmark competitors, evaluate imaging-driven growth opportunities and support strategy in a fast-evolving peripheral vascular imaging segment.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
By iData Research - 68 pages - 6 charts, 35 figures
Executive Summary
The global peripheral intravascular ultrasound market was valued at over $240 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 6.9% to reach $383 million by 2032.
The full report suite on the global market for peripheral intravascular ultrasound, or IVUS, covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and average selling price data, while also extending projections through 2032 to provide a forward-looking view of market development. This description follows the same structure and sequencing used in the attached example document, adapted to the peripheral IVUS market and its specific clinical and commercial dynamics .
This report provides detailed analysis of the global peripheral IVUS market, including unit sales, procedure numbers, average selling prices, market size, market shares, growth trends and forecasts through 2032, with historical data to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and competitive analysis of the leading participants in the category. Although this is a more specialized imaging segment within peripheral vascular intervention, it is becoming increasingly important because physicians are relying more heavily on real-time vessel visualization during complex procedures.
A major trend shaping the market is the ongoing development of high-definition imaging technologies and smaller catheter systems. These improvements are helping physicians visualize vessel structures more clearly and navigate more effectively during intervention. As a result, IVUS is becoming more valuable in lesion assessment, stent sizing, post-placement optimization and treatment of complex anatomy. This is especially relevant in procedures where angiography alone may not provide enough detail to support confident decision-making.
Growth is also being driven by expanding use in venous intervention and by the steady rise in peripheral procedure volume associated with aging populations and higher peripheral arterial disease prevalence.
Market Overview
The global peripheral intravascular ultrasound market includes catheter-based imaging devices used to visualize blood vessels from inside the lumen during peripheral vascular procedures. Unlike angiography, which shows vessel outlines using contrast and X-ray imaging, IVUS provides real-time cross-sectional information about vessel size, plaque burden, lumen shape and wall structure. This makes it an important tool in procedures where accurate anatomical understanding can improve treatment planning and final procedural results.
Peripheral IVUS has become more relevant as vascular interventions have grown more complex. Many peripheral procedures now involve long lesions, calcified anatomy, venous obstruction, difficult access routes or borderline sizing decisions for stent grafts and other implants. In these situations, physicians often need more precise information than angiography alone can provide. IVUS addresses that need by helping define vessel diameter, lesion length, plaque composition and true lumen position during the procedure itself.
Overall, the peripheral IVUS market is positioned between imaging, intervention and procedural planning. It is not a therapy by itself, but it plays a key enabling role in helping physicians make better decisions during treatment. That role is becoming more important as peripheral interventions continue moving toward more complex and more image-dependent care.
Market Drivers
Venous Treatments
One of the strongest drivers in the global peripheral IVUS market is the growth of venous treatment. Philips, the market leader in IVUS, actively positioned its products alongside venous intervention, and this strategy helped make IVUS closely associated with deep venous procedures. After the results of the VIDIO trial, use of IVUS became more established in venous cases involving the inferior vena cava, common iliac vein, iliofemoral obstruction and common femoral vein obstruction.
This is highly important because penetration rates of IVUS in deep venous treatments are already over 50%. That level of established use means venous procedures are not just a future opportunity. They are already a major source of demand. As more venous disease is diagnosed and treated, this part of the market is expected to contribute meaningful growth. Because IVUS provides sizing and lesion detail that venography alone may miss, it has become an important part of workflow in many of these cases.
Demographic Factors Drive Peripheral Procedures
Another major growth driver is the aging global population. Peripheral arterial disease becomes more common with age, especially in patients aged 65 and older. As the number of older adults rises worldwide, the total number of peripheral vascular procedures is expected to increase. Even if IVUS penetration rates within those procedures do not change dramatically, a larger procedural base still supports higher catheter unit sales.
This driver is structural and long term. It is not tied to one company or one indication. Instead, it reflects the fact that more patients will require vascular intervention as the burden of PAD grows. Because IVUS is increasingly used to guide peripheral interventions, growth in the total number of cases supports continued expansion of the imaging category.
Clinical Advantages of IVUS in EVAR and TEVAR Procedures
Peripheral IVUS is also supported by its advantages in EVAR and TEVAR procedures. In these cases, IVUS can help assess anatomy when CT-based measurements are borderline or when anatomy may have changed between the original scan and the actual intervention. It can also help confirm key dimensions before device deployment, which improves physician confidence in stent graft selection and placement.
IVUS also helps reduce the amount of radiographic contrast needed during EVAR and TEVAR. This is useful because contrast media can cause patient discomfort and can be undesirable in patients with renal risk. In dissection cases, IVUS provides especially valuable guidance because it can help confirm that equipment remains within the true vessel lumen. The ability of IVUS to identify dissections at a much higher rate than angiography makes it a practical and clinically meaningful support tool in complex aortic work.
These benefits are important because they show that IVUS is not only a lesion imaging tool. It also functions as a procedural confirmation technology in some of the more technically demanding vascular cases. As EVAR and TEVAR continue evolving, this should help support growing adoption.
Market Limiters
Capital Equipment Cost Limits Adoption
The biggest limiter in the global peripheral IVUS market is the cost of capital equipment. An IVUS system requires both the disposable catheter and the IVUS console. While catheter use creates recurring revenue, the console represents a major upfront investment. For cost-sensitive hospitals and facilities, this can delay adoption even when physicians see clinical value in the technology.
This matters because installed base drives long-term catheter demand. If facilities delay purchasing the console, catheter unit growth is naturally limited as well. Smaller centers or lower-volume accounts may find it difficult to justify the initial investment, especially when competing imaging or procedural priorities exist.
Fuzzy Images and Learning Curve
Another important limiter is the challenge of image interpretation. IVUS images can be difficult for untrained users to read. They are often grainy and do not always provide the kind of easily intuitive detail seen in some other imaging modalities. Physicians need training and practical experience before they are comfortable using the technology confidently in routine practice.
The training burden is not extreme, but it is real. Any technology that requires added interpretation skill creates a barrier to wider use, especially in accounts where physician time is limited or where procedural teams are already comfortable with angiography. This can slow uptake and favor more familiar imaging methods.
Developing Technologies
Peripheral IVUS also faces competition from developing technologies such as OCT and CT-based vascular imaging. These are not yet the standard in the periphery, but their broader use in coronary procedures and ongoing reimbursement efforts around newer technologies suggest they could become more influential over time.
One reason this matters is that some alternative imaging approaches can generate cleaner visuals or more three-dimensional anatomical models. These capabilities can be useful in identifying dissections, thrombi, tissue prolapse and incomplete stent apposition. As these technologies continue to mature, they are expected to cannibalize part of the IVUS market.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Qualitative Coverage
Market drivers and limiters, growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Time Frame
Base year 2025, historical data to 2022 and forecasts through 2032.
Regional Coverage
North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.
Data Types Included
Unit sales, average selling prices, procedure numbers, market size and growth trends.
This report is designed to support strategic planning and competitive benchmarking by combining detailed market sizing with practical insight into where IVUS creates value within peripheral intervention.
Markets Covered and Segmentation
The report covers the Global Peripheral Intravascular Ultrasound Market.
This market is analyzed as a dedicated imaging category within peripheral vascular intervention. While the report does not subdivide the category into multiple device families in the same way as some larger therapeutic markets, it evaluates the full market by units, ASPs, market value, growth rates and regional performance.
The analysis supports understanding of peripheral IVUS use across arterial, venous and EVAR or TEVAR-related procedures, with forecasts through 2032 and historical data to 2022.
Competitive Analysis
Philips held the leading position in the peripheral IVUS catheter market in 2025. The company offers a broad peripheral IVUS catheter portfolio that includes Visions PV .018, Visions PV .035, Visions PV .014P and Visions PV .014P RX. Its Eagle Eye Platinum and Eagle Eye Platinum ST catheters are also used in both coronary and peripheral procedures and are compatible with the Core and Core Mobile IVUS consoles. Philips has a major competitive advantage because its phased-array IVUS catheters are generally viewed as simpler and more workflow-friendly than rotational IVUS catheters. The company is also the only major supplier with a full range of 0.014 inch, 0.018 inch and 0.035 inch peripheral IVUS catheter options, which strengthens its position across both arterial and venous indications. Its especially strong presence in venous work remains one of the clearest supports for its leadership.
Boston Scientific ranked second in the peripheral IVUS catheter market in 2025. Its position is supported by the OptiCross18 peripheral IVUS catheter, which works with the iLab and POLARIS systems. Boston Scientific performs well in peripheral arterial disease indications because of its broad peripheral intervention portfolio and the ability to pair IVUS with complementary treatment devices. However, the company faces more difficulty in venous indications because its catheter size offering is not as broad as Philips’ lineup. This limits its competitive flexibility in some procedures and helps explain why Philips remains stronger in the venous segment.
Overall, competition in the peripheral IVUS market is shaped by catheter breadth, imaging workflow, installed console base and the ability to support both arterial and venous procedures through a coherent product portfolio.
Technology and Practice Trends
One of the most important trends in the peripheral IVUS market is the ongoing development of high-definition imaging technology. Better image quality improves vessel visualization and helps physicians make more confident decisions during intervention.
Another major trend is catheter miniaturization. Smaller catheter systems improve navigational capabilities and allow IVUS to be used more easily across different vessel types and procedural settings.
Venous adoption is also a key practice trend. IVUS is becoming strongly associated with deep venous intervention, and this is helping shift the market toward broader use in non-arterial cases.
Finally, IVUS is increasingly being used as a procedural optimization tool rather than only a diagnostic adjunct. Its role in sizing, confirming anatomy, reducing contrast use and guiding complex cases is expanding as operators seek more precision during intervention.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Deliverables
68 pages of detailed market analysis, segmentation and forecast data.
6 charts and 35 figures covering market performance, regional trends and competitive positioning.
Methodology Appendix and Acronym Glossary.
Licensing options include single-user, site and enterprise.
Why This Report
Where are the strongest growth opportunities in the global peripheral IVUS market through 2032?
How much of future expansion is being driven by venous procedures, PAD growth and EVAR or TEVAR support use?
What role do catheter miniaturization and higher-definition imaging play in future adoption?
How do capital costs, image interpretation challenges and alternative technologies limit broader market penetration?
Which companies lead the market, and how do their catheter portfolios shape their competitive positions?
How can suppliers and investors evaluate where peripheral IVUS fits within the broader future of image-guided vascular intervention?
The Global Peripheral Intravascular Ultrasound Market Report from iData Research answers these questions with detailed market sizing, pricing analysis, competitive intelligence and forecasting. Use it to benchmark competitors, evaluate imaging-driven growth opportunities and support strategy in a fast-evolving peripheral vascular imaging segment.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Table of Contents
32 Pages
- List Of Figures
- List Of Charts
- Research Methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems And Perform Secondary Research
- Step 3: Preparation For Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast And Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review And Market Release
- Step 9: Customer Feedback And Market Monitoring
- Impact Of Global Tariffs
- Peripheral Intravascular Ultrasound Market
- 14.1 Executive Summary
- 14.1.1 Global Peripheral Intravascular Ultrasound Market Overview
- 14.1.2 Competitive Analysis
- 14.1.3 Procedures Included
- 14.1.4 Regions Included
- 14.2 Introduction
- 14.3 Procedure Numbers
- 14.4 Market Analysis And Forecast
- 14.5 Drivers And Limiters
- 14.5.1 Market Drivers
- 14.5.2 Market Limiters
- 14.6 Competitive Market Share Analysis
- Abbreviations
- Chart 14-1: Peripheral IVUS Market, Global, 2025 & 2032
- Chart 14-2: Peripheral IVUS Procedures, Global, 2025
- Chart 14-3: Peripheral IVUS Procedures by Region, Global, 2022 – 2032
- Chart 14-4: Peripheral IVUS Market, Global, 2022 – 2032
- Chart 14-5: Leading Competitors, Peripheral IVUS Market, Global, 2025
- Figure 14-1: Peripheral IVUS Procedures Covered
- Figure 14-2: Peripheral IVUS Regions Covered, Global (1 of 2)
- Figure 14-3: Peripheral IVUS Regions Covered, Global (2 of 2)
- Figure 14-4: Peripheral IVUS Procedures by Region, Global, 2022 – 2032
- Figure 14-5: Peripheral IVUS Procedures by Country, North America, 2022 – 2032
- Figure 14-6: Peripheral IVUS Procedures by Country, Latin America, 2022 – 2032 (1 of 2)
- Figure 14-7: Peripheral IVUS Procedures by Country, Latin America, 2022 – 2032 (2 of 2)
- Figure 14-8: Peripheral IVUS Procedures by Country, Western Europe, 2022 – 2032
- Figure 14-9: Peripheral IVUS Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)
- Figure 14-10: Peripheral IVUS Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)
- Figure 14-11: Peripheral IVUS Procedures by Country, Middle East, 2022 – 2032
- Figure 14-12: Peripheral IVUS Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)
- Figure 14-13: Peripheral IVUS Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)
- Figure 14-14: Peripheral IVUS Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)
- Figure 14-15: Peripheral IVUS Procedures by Country, Africa, 2022 – 2032
- Figure 14-16: Peripheral IVUS Market, Global, 2022 – 2032
- Figure 14-17: Units Sold by Region, Peripheral IVUS Market, Global, 2022 – 2032
- Figure 14-18: Average Selling Price by Region, Peripheral IVUS Market, Global, 2022 – 2032 (US$)
- Figure 14-19: Market Value by Region, Peripheral IVUS Market, Global, 2022 – 2032 (US$M)
- Figure 14-20: Leading Competitors, Peripheral IVUS Market, Global, 2025
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
